MGNX
MacroGenics Inc
NASDAQ: MGNX · HEALTHCARE · BIOTECHNOLOGY
$3.08
+4.76% today
Updated 2026-04-30
Market cap
$193.86M
P/E ratio
—
P/S ratio
1.30x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$1 – $4
Volume
1.1M
MacroGenics Inc (MGNX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $47.05M | $59.65M | $56.75M | $47.26M | $100.85M | $86.58M | $155.52M | $60.12M | $62.02M | $97.76M | $75.64M | $151.94M | $57.19M | $148.34M | $149.50M |
| Revenue growth (YoY) | — | +26.8% | -4.8% | -16.7% | +113.4% | -14.2% | +79.6% | -61.3% | +3.2% | +57.6% | -22.6% | +100.9% | -62.4% | +159.4% | +0.8% |
| Cost of revenue | $50.81M | $54.66M | $56.48M | $84.29M | $98.27M | $122.09M | $147.23M | $190.83M | $195.31M | $193.20M | $2.65M | $7.38M | $8.22M | $12.30M | $43.18M |
| Gross profit | $47.05M | $59.65M | $56.75M | $47.26M | $100.85M | $86.58M | $155.52M | $60.12M | $62.02M | $97.76M | $72.99M | $144.56M | $48.97M | $136.04M | $106.32M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.5% | 95.1% | 85.6% | 91.7% | 71.1% |
| R&D | $41.09M | $45.43M | $46.58M | $70.19M | $98.27M | $122.09M | $147.23M | $190.83M | $195.31M | $193.20M | $214.58M | $207.03M | $166.58M | $177.19M | $147.17M |
| SG&A | $10.87M | $10.19M | $11.09M | $15.93M | $22.77M | $29.83M | $32.65M | $40.50M | $46.06M | $42.74M | $63.01M | $58.95M | $52.19M | $71.05M | $39.16M |
| Operating income | $5.25M | $8.21M | $365979.00 | $-38.31M | $-20.18M | $-60.04M | $-22.14M | $-171.21M | $-177.19M | $-131.06M | $-202.79M | $-121.42M | $-168.24M | $-110.58M | $-72.84M |
| Operating margin | 11.2% | 13.8% | 0.6% | -81.1% | -20.0% | -69.3% | -14.2% | -284.8% | -285.7% | -134.1% | -268.1% | -79.9% | -294.2% | -74.5% | -48.7% |
| EBITDA | $6.40M | $9.17M | $1.56M | $-36.49M | $-17.32M | $-52.43M | $-14.91M | $-162.05M | $-164.88M | $-119.10M | $-191.54M | $-109.55M | $2.02M | $-57.37M | $-65.67M |
| EBITDA margin | 13.6% | 15.4% | 2.7% | -77.2% | -17.2% | -60.6% | -9.6% | -269.5% | -265.8% | -121.8% | -253.2% | -72.1% | 3.5% | -38.7% | -43.9% |
| EBIT | $5.25M | $8.21M | $365979.00 | $-38.31M | $-20.18M | $-60.04M | $-22.14M | $-171.25M | $-177.19M | $-131.06M | $-202.79M | $-121.42M | $-7.63M | $-64.91M | $-72.84M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $680000.00 | $263000.00 | $1.43M | $1.11M | $8.51M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $6.72M | $8.36M | $-260835.00 | $-38.31M | $-20.14M | $-58.53M | $-19.63M | $-171.45M | $-151.81M | $-117.78M | $-190.86M | $-120.02M | $-9.06M | $-66.97M | $-74.62M |
| Net income growth (YoY) | — | +24.5% | -103.1% | -14588.6% | +47.4% | -190.6% | +66.5% | -773.6% | +11.5% | +22.4% | -62.0% | +37.1% | +92.5% | -639.3% | -11.4% |
| Profit margin | 14.3% | 14.0% | -0.5% | -81.1% | -20.0% | -67.6% | -12.6% | -285.2% | -244.8% | -120.5% | -252.3% | -79.0% | -15.8% | -45.1% | -49.9% |